IBDEI1T0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30654,1,3,0)
 ;;=3^Anaphylactic Reaction d/t Adverse Eff Drug/Med Prop Admin,Init Encnt
 ;;^UTILITY(U,$J,358.3,30654,1,4,0)
 ;;=4^T88.6XXA
 ;;^UTILITY(U,$J,358.3,30654,2)
 ;;=^5055808
 ;;^UTILITY(U,$J,358.3,30655,0)
 ;;=T81.10XA^^121^1525^16
 ;;^UTILITY(U,$J,358.3,30655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30655,1,3,0)
 ;;=3^Postprocedural Shock,Unspec,Init Encnt
 ;;^UTILITY(U,$J,358.3,30655,1,4,0)
 ;;=4^T81.10XA
 ;;^UTILITY(U,$J,358.3,30655,2)
 ;;=^5054455
 ;;^UTILITY(U,$J,358.3,30656,0)
 ;;=T81.12XA^^121^1525^15
 ;;^UTILITY(U,$J,358.3,30656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30656,1,3,0)
 ;;=3^Postprocedural Septic Shock,Init Encnt
 ;;^UTILITY(U,$J,358.3,30656,1,4,0)
 ;;=4^T81.12XA
 ;;^UTILITY(U,$J,358.3,30656,2)
 ;;=^5054461
 ;;^UTILITY(U,$J,358.3,30657,0)
 ;;=Z45.2^^121^1525^18
 ;;^UTILITY(U,$J,358.3,30657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30657,1,3,0)
 ;;=3^VAD Adjustment & Management Encounter
 ;;^UTILITY(U,$J,358.3,30657,1,4,0)
 ;;=4^Z45.2
 ;;^UTILITY(U,$J,358.3,30657,2)
 ;;=^5062999
 ;;^UTILITY(U,$J,358.3,30658,0)
 ;;=Z71.1^^121^1525^11
 ;;^UTILITY(U,$J,358.3,30658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30658,1,3,0)
 ;;=3^Feared Hlth Complaint-No Diagnosis Made
 ;;^UTILITY(U,$J,358.3,30658,1,4,0)
 ;;=4^Z71.1
 ;;^UTILITY(U,$J,358.3,30658,2)
 ;;=^5063243
 ;;^UTILITY(U,$J,358.3,30659,0)
 ;;=Z00.6^^121^1525^9
 ;;^UTILITY(U,$J,358.3,30659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30659,1,3,0)
 ;;=3^Exam for Nrml Cmprsn & Ctrl in Clncl Research Prog
 ;;^UTILITY(U,$J,358.3,30659,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,30659,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,30660,0)
 ;;=Z00.8^^121^1525^12
 ;;^UTILITY(U,$J,358.3,30660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30660,1,3,0)
 ;;=3^General Examination Encounter
 ;;^UTILITY(U,$J,358.3,30660,1,4,0)
 ;;=4^Z00.8
 ;;^UTILITY(U,$J,358.3,30660,2)
 ;;=^5062611
 ;;^UTILITY(U,$J,358.3,30661,0)
 ;;=Z01.818^^121^1526^3
 ;;^UTILITY(U,$J,358.3,30661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30661,1,3,0)
 ;;=3^Preprocedural Examination
 ;;^UTILITY(U,$J,358.3,30661,1,4,0)
 ;;=4^Z01.818
 ;;^UTILITY(U,$J,358.3,30661,2)
 ;;=^5062628
 ;;^UTILITY(U,$J,358.3,30662,0)
 ;;=Z01.810^^121^1526^2
 ;;^UTILITY(U,$J,358.3,30662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30662,1,3,0)
 ;;=3^Preprocedural Cardiovascular Examination
 ;;^UTILITY(U,$J,358.3,30662,1,4,0)
 ;;=4^Z01.810
 ;;^UTILITY(U,$J,358.3,30662,2)
 ;;=^5062625
 ;;^UTILITY(U,$J,358.3,30663,0)
 ;;=Z01.811^^121^1526^4
 ;;^UTILITY(U,$J,358.3,30663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30663,1,3,0)
 ;;=3^Preprocedural Respiratory Examination
 ;;^UTILITY(U,$J,358.3,30663,1,4,0)
 ;;=4^Z01.811
 ;;^UTILITY(U,$J,358.3,30663,2)
 ;;=^5062626
 ;;^UTILITY(U,$J,358.3,30664,0)
 ;;=Z48.89^^121^1526^1
 ;;^UTILITY(U,$J,358.3,30664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30664,1,3,0)
 ;;=3^Postsurgical Aftercare
 ;;^UTILITY(U,$J,358.3,30664,1,4,0)
 ;;=4^Z48.89
 ;;^UTILITY(U,$J,358.3,30664,2)
 ;;=^5063055
 ;;^UTILITY(U,$J,358.3,30665,0)
 ;;=J95.821^^121^1527^5
 ;;^UTILITY(U,$J,358.3,30665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30665,1,3,0)
 ;;=3^Acute Postprocedural Respiratory Failure
 ;;^UTILITY(U,$J,358.3,30665,1,4,0)
 ;;=4^J95.821
 ;;^UTILITY(U,$J,358.3,30665,2)
 ;;=^5008338
 ;;^UTILITY(U,$J,358.3,30666,0)
 ;;=J96.00^^121^1527^8
 ;;^UTILITY(U,$J,358.3,30666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30666,1,3,0)
 ;;=3^Acute Respiratory Failure,Unspec
 ;;^UTILITY(U,$J,358.3,30666,1,4,0)
 ;;=4^J96.00
 ;;^UTILITY(U,$J,358.3,30666,2)
 ;;=^5008347
